Efficacy and Safety of Oral Nalbuphine Extended Release in Prurigo Nodularis: Results of a Phase 2, Randomized, Controlled Trial with an Open Open-Label Extension Phase. J of Skin. 2021;5(1):s29. doi:10.25251/skin.5.supp.29